Given the pivotal role of the PI3K/AKT signaling pathway in NK cell activation and cytotoxicity, we hypothesize that HMGB2 may modulate NK cell anti-tumor function via this signaling axis. The gene discussed is HMGB2; the disease is neoplasm.